Judges for the 2008 45 Under 45
To judge the Emerging Leadership Awards, Pharm Exec called on its Editorial Advisory Board members as well as other trusted sources. A comprehensive listing of those judges is included below:
Jeffrey Aronin, Ovation Pharmaceuticals
David Balekdjian, The Bruckner Group
Stan Bernard, MD, Bernard Associates
Steve Bliss, Innovex
Kevin Butler, Heritage Partners
Gary Cupit, Somnus Therapeutics
Todd Davis, Cowen Healthcare Royalty Partners
Craig Dunkley, Campbell Alliance
Rob Dhoble, DAS Healthcare, Omnicom
Sander Flaum, Flaum Partners
Cliff Kalb, C.Kalb & Associates, LLC
Mike Luby, TargetRx
Wayne Pines, APCO Worldwide
Peter Pitts, Center for Medicines in the Public Interest; Manning, Selvage & Lee
Douglas Plotkin, PA Consulting
Charlene Prounis, Flashpoint Medica
Mason Tenaglia, Amundsen Group
Alex Scott, Eisai
David Snow, AstraZeneca
Catherine Sohn, GlaxoSmithKline
Steve Rauschkolb, The Crisfield Group
Charlotte Sibley, Shire Pharmaceuticals
David Stern, EMD Serono
Bill Trombetta, St. Joseph’s University
Ceci Zak, Roche
The Weight-Loss Gold Rush: Legal and Regulatory Implications
July 11th 2024Jim Shehan, chair of the FDA Regulatory practice, Lowenstein Sandler, discusses how the FDA and other regulators likely to respond to the increased public interest and potential off-label use of GLP-1 drugs, what needs to be done for GLP-1s to be covered, advice for investors and financiers considering entering the weight-loss medication market and more.
Healthcare Marketing Strategies for Reaching Diverse Audiences
May 14th 2024Amanda Powers-Han, Chief Marketing Officer, Greater Than One, and Pharmaceutical Executive Editorial Advisory Board member, discusses how improved DE&I in healthcare marketing strategies can not only reach diverse audiences more effectively but also contribute to improved patient care outcomes, challenges faced in crafting culturally sensitive messages, and much more.